Search clinical trials for: Tobramycin Solution for Inhalation
Total 1387 results
-
Bitop AGActive, not recruiting
-
Bitop AGCompletedCOPD | Particulate Matter Induced Inflammation of the LungGermany
-
Mylan Pharma UK Ltd.CompletedHealthy Volunteers Bioavailability StudyChina
-
Merck Sharp & Dohme LLCTerminated
-
Dartmouth-Hitchcock Medical CenterNovartis PharmaceuticalsTerminatedCystic FibrosisUnited States
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
Merck Sharp & Dohme LLCTerminated
-
Karolinska InstitutetCompletedThrombosis | Vascular Function | Microcirculation | Heated Tobacco Products | Blood Markers | Microvesicles | NETsSweden
-
Sutphin DrugsUnknownBlepharo ConjunctivitisUnited States
-
Hangzhou Sciwind Biosciences Co., Ltd.Completed
-
University College, LondonCompleted
-
University of Missouri-ColumbiaCompletedSARS-CoV 2 | ARDSUnited States
-
AstraZenecaCompleted
-
Gilead SciencesCompletedCystic FibrosisUnited States, France, Spain, Germany, Austria, Belgium, Italy, Netherlands, Poland
-
Spyryx Biosciences, Inc.CompletedCystic FibrosisUnited Kingdom, Canada, France, Italy, Portugal
-
GlaxoSmithKlineCompleted
-
Merck Sharp & Dohme LLCCompletedCystic Fibrosis
-
Kexing Biopharm Co., Ltd.RecruitingRespiratory Syncytial Virus InfectionsChina
-
Seventh Medical Center of PLA General HospitalActive, not recruiting
-
Chiesi Farmaceutici S.p.A.CompletedCystic FibrosisUkraine, France, Poland
-
Kamada, Ltd.CompletedAlpha-1 Antitrypsin DeficiencyUnited States
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease
-
Meiji Seika Pharma Co., Ltd.Completed
-
Merck Sharp & Dohme LLCCompletedCystic FibrosisUnited States, Australia, Canada, New Zealand
-
Boehringer IngelheimCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Ajou University School of MedicineNot yet recruitingSpinal Diseases
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedPrimary Sjögren's SyndromeUnited States, France, United Kingdom, Australia, Germany, Hungary, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Fondation Ophtalmologique Adolphe de RothschildUniversity Hospital, Strasbourg, France; Centre Hospitalier Régional Metz-ThionvilleTerminatedCOVID-19 | Acute Respiratory Distress SyndromeFrance
-
Boehringer IngelheimCompleted
-
Chiesi Farmaceutici S.p.A.Completed
-
Northwestern UniversityGenentech, Inc.UnknownHead and Neck CancerUnited States
-
BioMarck Pharmaceuticals, Ltd.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Apeiron BiologicsApeiron Respiratory Therapies GmbHCompleted
-
Peking University First HospitalCompletedPostoperative ComplicationsChina
-
AstraZenecaQuotient SciencesActive, not recruiting
-
BDD Pharma LtdAlgiPharma ASCompleted
-
Boehringer IngelheimRecruitingNetherton SyndromeBelgium, United Kingdom, Australia, Germany, China, Malaysia, United States, Japan, France, Israel, Bulgaria, Italy, Switzerland, Austria, Netherlands, Portugal
-
University of North Carolina, Chapel HillUnited TherapeuticsTerminatedRespiratory Distress Syndrome, AdultUnited States
-
Insmed IncorporatedWithdrawn
-
Neupharma SrlSintesi Research Srl; Pari Pharma GmbH; AptuitCompleted
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); Aires Pharmaceuticals, Inc.CompletedHeart FailureUnited States
-
Meiji Seika Pharma Co., Ltd.Completed
-
Olga TyuminaClinics of the Federal State Budgetary Educational Institution SSMU; Samara...UnknownCOVID-19 | Covid19 | SARS-CoV-2 PNEUMONIARussian Federation
-
Mayo ClinicRecruitingLower Urinary Tract Obstructive Syndrome | Renal Failure Congenital | Congenital Renal Anomaly Nos | Renal Agenesis and DysgenesisUnited States
-
Frontier Biotechnologies Inc.RecruitingEvaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19Mild to Moderate COVID-19China